Evidence map›Paper›PMID 22658745›Full record

ArticleCurrent opinion in neurobiology2012

Cognitive and pharmacological insights from the Ts65Dn mouse model of Down syndrome.

Aarti Ruparelia, Matthew L Pearn, William C Mobley

Abstract read
In one paragraph

Article in Current opinion in neurobiology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
4.1field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Aarti RupareliaDepartment of Neurodegenerative Disease, UCL Institute of Neurology, London, WC1N 3BG, UK.
Matthew L Pearn
William C Mobley
University of California, San Diego · USUniversity College London · GB

Funding

Center for Protein Folding Machinery (RMI)PN2EY016525 · NEI · BAYLOR COLLEGE OF MEDICINE · PI CHIU, WAH · 2005 to 2015
$33.6M
Genetic Basis of Failed Cognition in Young and Aged Mouse Models of Trisomy 21R01NS066072 · NINDS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI MOBLEY, WILLIAM C, YU, EUGENE · 2010 to 2014
$3.2M
NERVE GROWTH FACTOR--TROPHIC EFFECTS ON CNS NEURONSR01NS024054 · NINDS · UNIVERSITY OF CALIFORNIA SAN FRANCISCO · PI MOBLEY, WILLIAM C · 1986 to 2008
$1.6M
Disrupted Transport of NGF-TrKA Signaling in Mouse Models of Down SyndromeR01NS055371 · NINDS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI MOBLEY, WILLIAM C · 2007 to 2010
$1.6M
The role of caveolin-1 on anesthetic-mediated neurotoxicityK08GM124500 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI PEARN, MATTHEW L · 2018 to 2022
$1.0M
NEI NIH HHS PN2 EY016525NIGMS NIH HHS K08 GM124500NIGMS NIH HHS L40 GM125142NINDS NIH HHS R01 NS024054NINDS NIH HHS R01 NS055371NINDS NIH HHS R01 NS066072NINDS NIH HHS R01 NS066072-01A1NINDS NIH HHS R01 NS24054
6 · The paper itself

Abstract

Down syndrome (DS) is a multi-faceted condition resulting in the most common genetic form of intellectual disability. Mouse models of DS, especially the Ts65Dn model, have been pivotal in furthering our understanding of the genetic, molecular and neurobiological mechanisms that underlie learning and memory impairments in DS. Cognitive and pharmacological insights from the Ts65Dn mouse model have led to remarkable translational progress in the development of therapeutic targets and in the emergence of DS clinical trials. Unravelling the pathogenic role of trisomic genes on human chromosome 21 and the genotype-phenotype relationship still remains a pertinent goal for tackling cognitive deficits in DS.

Indexed as

AnimalsChromosomes, Human, Pair 21Cognition DisordersDisease Models, AnimalDown SyndromeHumansMiceMice, TransgenicNeuroprotective AgentsNeuroprotective Agents

Identifiers

PMID22658745
PMCPMC3434300
OpenAlexW1968140551

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.